Molecular Diagnostics Market

Molecular Diagnostics Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 246

To learn more about this report, request a free sample copy

Molecular Diagnostics Market Overview

The report is titled ‘Molecular Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Molecular Diagnostics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The Molecular Diagnostics market is expected to grow at a significant rate in the near future.

The global Molecular Diagnostics market is estimated to reach at a value of US$ 9.8 Bn by the end of 2020 and expected to reach at a value of US$ xx Bn by 2028 with a significant CAGR of 8.7%

Molecular Diagnostics Introduction

Molecular diagnostics, also commonly known as molecular pathology, can be comprehended as a medical procedure that comprises taking samples of DNA or RNA from an individual’s body, which is a exclusive genetic code found in human cells, and examining the patterns for danger signs that can identify and diagnose the probable emergence of a specific ailment. The molecular diagnostic tests are usually performed to figure out whether or not patients have a gene mutation related with a specific ailment, either as an hereditary or a captured mutation. The test can also be performed to determine a common inherited hereditary cancer. Hereditary disorders can be determined at the newborn, prenatal, and adult stages of life.

In addition, the molecular diagnostics test is also performed when there is a need to determine whether a patient has become immune or resistant to a specific drug and needs to change or replace course in a clinical regime. For instance, an HIV patient can be observed by a quantitative molecular test to identify whether or not the viral load of the specific disease has considerably surged, which is an indication of resistance to the medical treatment. The patient’s HIV can further be DNA sequenced to identify if the mutation which is considered to be related with resistance is found.

Molecular Diagnostics Market Dynamics

There are abundant strong driving factors owing to which the global molecular diagnostics market is projected to witness significant growth in the coming years. One of the key factors that is majorly boosting the growth of the global molecular diagnostics industry is the invariably increasing incidence of infectious diseases, including HPV, influenza, HIV, hepatitis, and tuberculosis as well as different types of cancers among the population across the world.

Conventionally, the antimicrobial therapeutics is adopted for treating infectious diseases, however, the molecular diagnostics are strongly replacing convention methods due to the fact that conventional methods are not competent enough to combat the emergence of drug-resistant pathogens and viruses. Such factors are also strongly strengthening the growth of the global molecular diagnostics market.

In addition, there have been numerous technological advances in the area of molecular diagnostics which further escalates its potential and makes it competent enough to diagnose, prevent, and treat various chronic disorders and diseases effectively, which positively fuels the growth of the global molecular diagnostics market in the forthcoming years.

Moreover, the rising prevalence of cancer, globally, is also expected to give a positive push to the growth of the global molecular diagnostics market in the years to come. However, the legal and regulatory requirements for the molecular diagnostics are becoming stringent day after day, which is likely to act as a restraining factor for the growth of the global molecular diagnostics market over the forecast period. Furthermore, the high cost of disease diagnostics is also anticipated to hold the growth of the global market molecular diagnostics to the bounds.

Nevertheless, the rising trend of Point of Care diagnostics in the global market is estimated to accelerate the growth of the global molecular diagnostics market in the near future. In addition to that, there is a soaring number of R&D initiatives in developing economies, at present, which further positively fuels the growth of the global molecular diagnostics market.

Molecular Diagnostics Market Segmentation

The global molecular diagnostics market is segmented on the basis of product & services, technology, application, end-users and region. On the basis of the product & services, the molecular diagnostics market is segmented into Reagents & Kits, instruments, and software & services. On the basis of technology, the market is divided into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and NGS, DNA Microarrays, In Situ Hybridization, and Other Technologies. On the basis of application, the market is segmented into Infectious Disease, Oncology, Genetic Tests, and Other Applications. Further, the market is segmented on the basis of end-users into Hospital and Academic Laboratories, Reference Laboratories, and Other End-Users.

The research report classifies the global molecular diagnostics market based on Product & Service, Technology, Application, End-User and regions.

By Product & Service

Reagents & Kits

Instruments

Software and Service

By Technology

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

DNA Sequencing and NGS

DNA Microarrays

In Situ Hybridization

Other Technologies

By Application

Infectious Disease

Oncology

Genetic Tests

Other Applications

By End-User

Hospital and Academic Laboratories

Reference Laboratories

Other End-Users

Molecular Diagnostics Market Key Players

The global molecular diagnostics market is dominated by Abbott Laboratories, Becton, Dickinson, and Company & Biomérieux Sa & Danaher Corporation, QIAGEN N.V. & among others.

MMC Overview on Molecular Diagnostics Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the molecular diagnostics market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Molecular Diagnostics

Advantages of Molecular Diagnostics

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market


To learn more about this report, request a free sample copy


1.    Global Molecular Diagnostics Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Molecular Diagnostics Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Molecular Diagnostics Market Snapshot

2.4.    Global Molecular Diagnostics Market Size And Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Molecular Diagnostics Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

3.    Molecular Diagnostics Assessment and Analysis

3.1.    Molecular Diagnostics Impact Analysis 

3.2.    Actions to encourage use of MUSIC STREAMING SERVICES

3.3.    Molecular Diagnostics Promotional Strategy Recommendation

3.4.    Road Map Analysis

3.5.    GAP Analysis

3.6.    Potential Analysis

4.    Covid-19 Impact on Molecular Diagnostics Market

4.1.    Impact Analysis of Covid-19 on the global Molecular Diagnostics market

4.2.    Effect On Value Chain

4.3.    Business Impact W.R.T Revenue 

4.4.    Volatility In Price 

4.5.    Effect On The Overall Trade 

4.6.    Market Impact Analysis In 2020 (Quarter Wise)

5.    Global Molecular Diagnostics Market, By Product & Services

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Product & Services

5.1.2.    BPS Analysis, By Product & Services

5.2.    Market Revenue (US$Mn) and Forecast, By Product & Services

5.2.1.    Reagents & Kits

5.2.2.    Instruments

5.2.3.    Software and Service

5.3.    Global Molecular Diagnostics Market Attractiveness Index, By Product & Services

6.    Global Molecular Diagnostics Market, By Technology

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Technology

6.1.2.    BPS Analysis, By Technology

6.2.    Market Revenue (US$Mn) and Forecast, By Technology

6.2.1.    Polymerase Chain Reaction (PCR)

6.2.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

6.2.3.    DNA Sequencing and NGS

6.2.4.    DNA Microarrays

6.2.5.    In Situ Hybridization

6.2.6.    Other Technologies

6.3.    Global Molecular Diagnostics Market Attractiveness Index, By Technology

7.    Global Molecular Diagnostics Market, By Application

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Application

7.1.2.    BPS Analysis, By Application

7.2.    Market Revenue (US$Mn) and Forecast, By Application

7.2.1.    Infectious Disease

7.2.2.    Oncology

7.2.3.    Genetic Tests

7.2.4.    Other Applications

7.3.    Global Molecular Diagnostics Market Attractiveness Index, By Application

8.    Global Molecular Diagnostics Market, By End-User

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By End-User

8.1.2.    BPS Analysis, By End-User

8.2.    Market Revenue (US$Mn) and Forecast, By End-User

8.2.1.    Hospital and Academic Laboratories

8.2.2.    Reference Laboratories

8.2.3.    Other End-Users

8.3.    Global Molecular Diagnostics Market Attractiveness Index, By End-User

9.    Global Molecular Diagnostics Market, By Region

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Region

9.1.2.    BPS Analysis, By Region

9.2.    Market Revenue (US$Mn) and Forecast, By Region

9.2.1.    North America

9.2.2.    Latin America

9.2.3.    Europe

9.2.4.    Asia Pacific

9.2.5.    Middle East 

9.2.6.    Africa

9.3.    Global Molecular Diagnostics Market Attractiveness Index, By Region

10.    North America Molecular Diagnostics Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market Revenue (US$Mn) and Forecast, By Country

10.2.1.    U.S. Molecular Diagnostics Market

10.2.2.    Canada Molecular Diagnostics Market

10.3.    North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services

10.3.1.    Reagents & Kits

10.3.2.    Instruments

10.3.3.    Software and Service

10.4.    North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology 

10.4.1.    Polymerase Chain Reaction (PCR)

10.4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

10.4.3.    DNA Sequencing and NGS

10.4.4.    DNA Microarrays

10.4.5.    In Situ Hybridization

10.4.6.    Other Technologies

10.5.    North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application

10.5.1.    Infectious Disease

10.5.2.    Oncology

10.5.3.    Genetic Tests

10.5.4.    Other Applications

10.6.    North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User

10.6.1.    Hospital and Academic Laboratories

10.6.2.    Reference Laboratories

10.6.3.    Other End-Users

10.7.    North America Molecular Diagnostics Market Attractiveness Index

10.7.1.    By Country

10.7.2.    By Product & Services

10.7.3.    By Technology 

10.7.4.    By Application

10.7.5.    By End-User

11.    Latin America Molecular Diagnostics Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    Brazil Molecular Diagnostics Market

11.2.2.    Mexico Molecular Diagnostics Market

11.2.3.    Rest Of Latin America Molecular Diagnostics Market

11.3.    Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services

11.3.1.    Reagents & Kits

11.3.2.    Instruments

11.3.3.    Software and Service

11.4.    Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology 

11.4.1.    Polymerase Chain Reaction (PCR)

11.4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

11.4.3.    DNA Sequencing and NGS

11.4.4.    DNA Microarrays

11.4.5.    In Situ Hybridization

11.4.6.    Other Technologies

11.5.    Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application

11.5.1.    Infectious Disease

11.5.2.    Oncology

11.5.3.    Genetic Tests

11.5.4.    Other Applications

11.6.    Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User

11.6.1.    Hospital and Academic Laboratories

11.6.2.    Reference Laboratories

11.6.3.    Other End-Users

11.7.    Latin America Molecular Diagnostics Market Attractiveness Index

11.7.1.    By Country

11.7.2.    By Product & Services

11.7.3.    By Technology 

11.7.4.    By Application

11.7.5.    By End-User

12.    Europe Molecular Diagnostics Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    U.K. Molecular Diagnostics Market

12.2.2.    Germany Molecular Diagnostics Market

12.2.3.    Italy Molecular Diagnostics Market

12.2.4.    France Molecular Diagnostics Market

12.2.5.    Spain Molecular Diagnostics Market

12.2.6.    Russia Molecular Diagnostics Market

12.2.7.    Rest Of Europe Molecular Diagnostics Market

12.3.    Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services

12.3.1.    Reagents & Kits

12.3.2.    Instruments

12.3.3.    Software and Service

12.4.    Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology 

12.4.1.    Polymerase Chain Reaction (PCR)

12.4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

12.4.3.    DNA Sequencing and NGS

12.4.4.    DNA Microarrays

12.4.5.    In Situ Hybridization

12.4.6.    Other Technologies

12.5.    Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application

12.5.1.    Infectious Disease

12.5.2.    Oncology

12.5.3.    Genetic Tests

12.5.4.    Other Applications

12.6.    Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User

12.6.1.    Hospital and Academic Laboratories

12.6.2.    Reference Laboratories

12.6.3.    Other End-Users

12.7.    Europe Molecular Diagnostics Market Attractiveness Index

12.7.1.    By Country

12.7.2.    By Product & Services

12.7.3.    By Technology 

12.7.4.    By Application

12.7.5.    By End-User

13.    Asia Pacific Molecular Diagnostics Market Analysis and Forecast, 2020–2028

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    China Molecular Diagnostics Market

13.2.2.    India Molecular Diagnostics Market

13.2.3.    Japan Molecular Diagnostics Market

13.2.4.    Australia and New Zealand Molecular Diagnostics Market

13.2.5.    South Korea Molecular Diagnostics Market

13.2.6.    Rest of Asia Pacific Molecular Diagnostics Market

13.3.    Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services

13.3.1.    Reagents & Kits

13.3.2.    Instruments

13.3.3.    Software and Service

13.4.    Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology 

13.4.1.    Polymerase Chain Reaction (PCR)

13.4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

13.4.3.    DNA Sequencing and NGS

13.4.4.    DNA Microarrays

13.4.5.    In Situ Hybridization

13.4.6.    Other Technologies

13.5.    Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application

13.5.1.    Infectious Disease

13.5.2.    Oncology

13.5.3.    Genetic Tests

13.5.4.    Other Applications

13.6.    Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User

13.6.1.    Hospital and Academic Laboratories

13.6.2.    Reference Laboratories

13.6.3.    Other End-Users

13.7.    Asia Pacific Molecular Diagnostics Market Attractiveness Index

13.7.1.    By Country

13.7.2.    By Product & Services

13.7.3.    By Technology 

13.7.4.    By Application

13.7.5.    By End-User

14.    Middle East Molecular Diagnostics Market Analysis and Forecast, 2020–2028

14.1.    Introduction

14.1.1.    Annual Growth Rate Comparison, By Country

14.1.2.    BPS Analysis, By Country

14.2.    Market (US$Mn) Forecast, By Country

14.2.1.    GCC Countries Molecular Diagnostics Market

14.2.2.    Israel Molecular Diagnostics Market

14.2.3.    Rest Of Middle East Molecular Diagnostics Market

14.3.    Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services

14.3.1.    Reagents & Kits

14.3.2.    Instruments

14.3.3.    Software and Service

14.4.    Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology 

14.4.1.    Polymerase Chain Reaction (PCR)

14.4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

14.4.3.    DNA Sequencing and NGS

14.4.4.    DNA Microarrays

14.4.5.    In Situ Hybridization

14.4.6.    Other Technologies

14.5.    Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application

14.5.1.    Infectious Disease

14.5.2.    Oncology

14.5.3.    Genetic Tests

14.5.4.    Other Applications

14.6.    Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User

14.6.1.    Hospital and Academic Laboratories

14.6.2.    Reference Laboratories

14.6.3.    Other End-Users

14.7.    Middle East Molecular Diagnostics Market Attractiveness Index

14.7.1.    By Country

14.7.2.    By Product & Services

14.7.3.    By Technology 

14.7.4.    By Application

14.7.5.    By End-User

15.    Africa Molecular Diagnostics Market Analysis and Forecast, 2020–2028

15.1.    Introduction

15.1.1.    Annual Growth Rate Comparison, By Country

15.1.2.    BPS Analysis, By Country

15.2.    Market (US$Mn) Forecast, By Country

15.2.1.    South Africa Countries Molecular Diagnostics Market

15.2.2.    Egypt Molecular Diagnostics Market

15.2.3.    North Africa Molecular Diagnostics Market

15.2.4.    Rest of Africa Molecular Diagnostics Market

15.3.    Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services

15.3.1.    Reagents & Kits

15.3.2.    Instruments

15.3.3.    Software and Service

15.4.    Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology 

15.4.1.    Polymerase Chain Reaction (PCR)

15.4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

15.4.3.    DNA Sequencing and NGS

15.4.4.    DNA Microarrays

15.4.5.    In Situ Hybridization

15.4.6.    Other Technologies

15.5.    Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application

15.5.1.    Infectious Disease

15.5.2.    Oncology

15.5.3.    Genetic Tests

15.5.4.    Other Applications

15.6.    Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User

15.6.1.    Hospital and Academic Laboratories

15.6.2.    Reference Laboratories

15.6.3.    Other End-Users

15.7.    Africa Molecular Diagnostics Market Attractiveness Index

15.7.1.    By Country

15.7.2.    By Product & Services

15.7.3.    By Technology 

15.7.4.    By Application

15.7.5.    By End-User

16.    Competitive Landscape

16.1.    Company Profiles

16.1.1.    Abbott Laboratories

16.1.1.1.    Company Overview

16.1.1.2.    Financial Overview

16.1.1.3.    Key Developments

16.1.1.4.    Strategies

16.1.1.5.    Product Analysis

16.1.2.    QIAGEN N.V.

16.1.3.    Becton

16.1.4.    Dickinson and Company 

16.1.5.    Biomérieux Sa & Danaher Corporation

17.    Acronyms

Select License Type

Frequently Asked Questions

The global molecular diagnostics market is estimated to reach at a value of US$ 9.8 Bn by the end of 2020 and expected to reach at a value of US$ xx Bn by 2028 with a significant CAGR of 8.7%

Invariably increasing incidence of infectious diseases, including HPV, influenza, HIV, hepatitis, and tuberculosis as well as different types of cancers among the population across the world. Technological advancement and increasing prevalence of cancer are also expected to fuel the growth of molecular diagnostics market

The global molecular diagnostics market is segmented on the basis of product & service, technology, application, end-user and regions.

The global molecular diagnostics market is dominated by Abbott Laboratories, Becton, Dickinson, and Company & Biomérieux Sa & Danaher Corporation, QIAGEN N.V. & among others.



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK